ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

In Vivo Dosimetry in the Urethra During Prostate Carbon Ion Radiotherapy

https://repo.qst.go.jp/records/2000516
https://repo.qst.go.jp/records/2000516
94691f1e-3699-43e1-83fe-eeb6c10d8238
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2024-06-07
タイトル
タイトル In Vivo Dosimetry in the Urethra During Prostate Carbon Ion Radiotherapy
言語 ja
言語
言語 jpn
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 松本 真之介

× 松本 真之介

松本 真之介

Search repository
松藤 成弘

× 松藤 成弘

松藤 成弘

Search repository
古場 裕介

× 古場 裕介

古場 裕介

Search repository
辻 比呂志

× 辻 比呂志

辻 比呂志

Search repository
抄録
内容記述タイプ Abstract
内容記述 Background/Aim: In vivo dosimetry can prevent dose delivery errors by directly measuring the dose of radiation administered to a patient. However, a method for in vivo dosimetry during carbon ion radiotherapy (CIRT) has not been established. Therefore, we investigated data from in vivo dosimetry of the urethra during CIRT for prostate cancer using small spherical diode dosimeters (SSDDs). Patients and Methods: This study included five patients enrolled in a clinical trial (jRCT identifier: jRCTs032190180) on which the use of four-fraction CIRT for prostate cancer was examined. The urethral dose during CIRT for prostate cancer was measured using the SSDDs inserted into the ureteral catheter. The relative error between the in vivo and calculated doses obtained using the Xio-N treatment planning system was determined. Additionally, a dose?response stability test for the in vivo dosimeter was performed under clinical conditions. Results: The relative error between the in vivo and calculated urethral doses ranged from 6 to 12%. The dose?response stability under clinical conditions of the measured dose was ?1%. Therefore, an error >1% would be due to an interfractional patient setup error in the large dose gradient in the urethra. Conclusion: The usefulness of in vivo dosimetry using SSDDs in CIRT and SSDDs’ potential for detecting dose delivery errors during CIRT is herein highlighted.
書誌情報 ANTICANCER RESEARCH

巻 43, 号 5, p. 2259-2264, 発行日 2023-03
出版者
出版者 International Institute of Anticancer Research
ISSN
収録物識別子タイプ ISSN
収録物識別子 0250-7005
DOI
識別子タイプ DOI
関連識別子 10.21873/anticanres.16389
戻る
0
views
See details
Views

Versions

Ver.1 2025-08-15 02:22:19.462175
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3